Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook from 2024 to 2034

The global advanced therapeutics pharmaceutical outsourcing market is expected to surge at a CAGR of 4.4% in the assessment period 2024 to 2034. The market value is projected to increase from US$ 7,592.8 million in 2024 to US$ 11,698.1 million by 2034. The advanced therapeutics pharmaceutical outsourcing market was valued at US$ 7,197.8 million in 2023 and is anticipated to exhibit a y-o-y growth of 4.5% in 2024.

Attributes Key Insights
Advanced Therapeutics Pharmaceutical Outsourcing Market Size in 2023 US$ 7,197.8 million
Estimated Advanced Therapeutics Pharmaceutical Outsourcing Market Value (2024E) US$ 7,592.8 million
Projected Advanced Therapeutics Pharmaceutical Outsourcing Market Revenue (2034F) US$ 11,698.1 million
Value-based CAGR (2024 to 2034) 4.4%

The increasing complexity of advanced therapeutic modalities, such as gene editing, cell therapy, and mRNA-based drugs, requires specialized knowledge and sophisticated manufacturing capabilities. Pharmaceutical companies are turning to outsourcing partners with advanced technical expertise to navigate the complexities of these novel therapies.

The growing pipeline of advanced therapeutic products, driven by breakthroughs in biotechnology and genomics, has led to a surging demand for outsourcing services. As pharmaceutical companies focus on expanding their portfolios with innovative therapies, outsourcing provides a scalable and cost-effective solution for development and production.

The globalization of clinical trials for advanced therapeutics requires a network of partners with a global presence. Outsourcing facilitates access to diverse patient populations, regulatory environments, and manufacturing capabilities worldwide, supporting efficient and accelerated clinical development.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Historical Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook

The global advanced therapeutics pharmaceutical outsourcing market recorded a historical CAGR of 3.3% from 2019 to 2023. The proliferation of cell and gene therapies represents a transformative shift in healthcare, offering innovative solutions for previously untreatable diseases. The increasing number of companies investing in developing these therapies has created a surge in demand for specialized expertise in manufacturing, quality control, and regulatory compliance.

Cell and gene therapies often involve intricate manufacturing processes, including gene editing, viral vector production, and cell culturing. Outsourcing allows pharmaceutical companies to tap into the specialized capabilities of contract manufacturing organizations (CMOs) with advanced facilities and expertise in these complex processes.

The variability in the production scale for cell and gene therapies, ranging from patient-specific treatments to large-scale manufacturing, necessitates a flexible and scalable approach. Outsourcing allows companies to adjust production volumes based on the specific requirements of their therapies without significant capital investment.

The regulatory landscape for cell and gene therapies is evolving rapidly. Outsourcing partners with a deep understanding of regulatory requirements can guide pharmaceutical companies through the complex approval processes, ensuring compliance and facilitating a smoother path to market.

The increasing adoption of cell and gene therapies is a pivotal driver propelling the growth of the advanced therapeutics pharmaceutical outsourcing market. As pharmaceutical companies prioritize these revolutionary treatment modalities, outsourcing partners equipped with specialized capabilities are becoming indispensable contributors to the successful development and commercialization of advanced therapeutics.

Drivers Propelling Advanced Therapeutics Pharmaceutical Outsourcing Market

A notable opportunity in the advanced therapeutics pharmaceutical outsourcing market lies in the expanding landscape of mRNA therapies. The increasing focus on mRNA therapies in cancer, infectious diseases, and genetic disorders presents a compelling opportunity for outsourcing partners. As pharmaceutical companies diversify their portfolios, outsourcing providers can offer specialized support in developing and manufacturing mRNA-based treatments.

The versatility of mRNA technology allows for developing a wide range of therapeutic applications. Outsourcing partners can capitalize on this diversity by providing tailored solutions for different mRNA-based treatments, contributing to expanding treatment options available to patients.

mRNA therapies often require specialized expertise in formulation and delivery methods to enhance efficacy and safety. Outsourcing providers focusing on mRNA can offer valuable insights and capabilities in optimizing these critical aspects of therapeutic development.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Key Advanced Therapeutics Pharmaceutical Outsourcing Market Trends and Analysis

  • Pharmaceutical firms are looking for outsourcing partners who can offer integrated solutions for the full manufacturing and drug development lifecycle.
  • Outsourcing partners with a solid grasp of regulatory standards and a track record of attaining compliance are highly sought after, especially in light of the changing regulatory landscape for innovative medicines.
  • The integration of cutting-edge technology, such as digitalization and automation, is intended to boost productivity and cut expenses in the pharmaceutical development and production processes.
  • In order to take advantage of cost savings, gain access to a variety of talent pools, and establish a foothold in new markets, pharmaceutical companies have kept looking at outsourcing opportunities on a worldwide scale.

Restrictive Factors for Advanced Therapeutics Pharmaceutical Outsourcing Market

The advanced therapeutics pharmaceutical outsourcing market, while experiencing significant growth opportunities, is also subject to several restrictive factors that pose challenges to its seamless development. When collectively considered, these factors can impact the market dynamics and hinder the full realization of its potential.

The primary restrictive factors is the complex and evolving regulatory landscape governing advanced therapeutics. Regulatory agencies face challenges in establishing clear guidelines as these therapies often involve cutting-edge technologies such as gene editing and cell therapy. This uncertainty can lead to delays in approvals and increase compliance burdens, impacting the speed at which outsourcing services can be leveraged.

The intricate nature of advanced therapeutics, including gene and cell therapies, demands sophisticated scientific expertise and technological capabilities. Finding outsourcing partners with the requisite knowledge in these rapidly advancing fields can be challenging. Technical challenges in scaling up production, maintaining quality, and ensuring consistency also contribute to the complexity.

While outsourcing can offer cost efficiencies, the initial investment in advanced therapeutic technologies and the need for specialized facilities can pose financial challenges. Companies can grapple with the cost of technology transfer, validation, and establishing robust quality control measures with outsourcing partners.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Adjacent Advanced Therapeutics Pharmaceutical Outsourcing Markets

The global advanced therapeutics pharmaceutical outsourcing market is set to be impacted by the peer or tangential markets in the healthcare division. These include other types of markets, such as the distance health technology industry and topical pain relief industry.

Analysis of these related industries can provide deeper insights that help develop unique differentiating strategies to pursue growth and opportunity in the advanced therapeutics pharmaceutical outsourcing market.

Demand for advanced therapeutics pharmaceutical outsourcing is projected to expand at a 4.4% CAGR during the forecast period. The need for outsourcing partners with expertise in the production, testing, and development of cutting-edge treatment modalities is increasing due to the emphasis on personalized medicine and the advancement of gene and cell therapies.

On the contrary, the distance health technology industry is poised to thrive at a higher CAGR of 16.3% through 2034. Governments and healthcare regulatory organizations are modifying policies to allow and control remote health technologies.

The topical pain relief industry is projected to expand at a CAGR of 5.3% from 2024 to 2034. Customers started paying closer attention to the components in their purchased medical supplies. Transparency in labeling is in vogue, and consumers' desire for natural and organic products devoid of dangerous substances is rising.

Advanced Therapeutics Pharmaceutical Outsourcing Industry:

Attributes Advanced Therapeutics Pharmaceutical Outsourcing Market
CAGR (2024 to 2034) 4.4%
Growth Factor The need for outsourcing partners with expertise in the production, testing, and development of these cutting-edge treatment modalities has increased as a result of the emphasis on personalized medicine and the advancement of gene & cell therapies.
Key Trend in Advanced Therapeutics Pharmaceutical Outsourcing Market Demand for outsourcing services is surging due to the growing interest in and funding for sophisticated medicines, such as gene, cell, and RNA-based therapies.

Distance Health Technology Industry:

Attributes Distance Health Technology Industry
CAGR (2024 to 2034) 16.3%
Growth Factor There is an increasing use of wearables and other linked devices for remote patient monitoring. Outside of conventional healthcare settings, these technologies enabled healthcare providers to monitor patients' vital signs and other health indicators.
Key Trend The demand for remote healthcare services is driving a rapid increase in the deployment of telemedicine systems. Technologies for remote monitoring, virtual visits, and video consultations are becoming more common.

Topical Pain Relief Market:

Attributes Topical Pain Relief Industry
CAGR (2024 to 2034) 5.3%
Growth Factor Firms are spending money on research and development to produce sophisticated formulas with improved effectiveness. This involved adding new components to the mix, like menthol, capsaicin, CBD, and other natural extracts, to improve pain relief.
Key Trend Firms are modifying their marketing and distribution tactics in response to consumers' growing preference for the ease of buying these things online.

Country-wise insights

The table below shows the estimated growth rates of the top five countries. China, Japan, and Spain are set to record high CAGRs of 7.0%, 3.2%, and 2.6%, respectively, through 2034.

Countries Value CAGR
United States 1.7%
China 7.0%
Japan 3.2%
Germany 1.6%
Spain 2.6%

Growing Demand for Personalized Medicine to Boost Sales in the United States

The United States dominated the global market with a 32.6% market share in 2023. The country is expected to exhibit a CAGR of 1.7% throughout the forecast period. The growing demand for personalized medicine and targeted therapies has fueled the development of advanced therapeutics. Outsourcing partners in the United States are well-positioned to support pharmaceutical companies in meeting the demands of a rapidly expanding market for personalized treatments.

The regulatory environment in the United States has increasingly supported advanced therapeutic products. Regulatory bodies, such as the United States Food and Drug Administration (FDA), have implemented expedited pathways and initiatives to facilitate the development and approval of innovative therapies. This regulatory support provides a conducive ecosystem for outsourcing partners to navigate regulatory requirements efficiently.

Rising Expertise in Advanced Therapeutics to Uplift China’s Market

In 2023, China held a dominant global revenue in East Asia’s market and contributed a share of 7.9% worldwide. The market is expected to grow at a CAGR of 7.0%.

China has witnessed rapid advancements in biotechnology and pharmaceutical research, leading to the development of cutting-edge technologies in gene and cell therapies. The country's commitment to innovation and growing expertise in advanced therapeutics, attract pharmaceutical companies seeking outsourcing partners with specialized capabilities.

China-based outsourcing partners increasingly participate in global clinical trials, allowing sponsors to conduct studies with a more diverse patient population. This globalization trend aligns with the growing emphasis on multi-regional clinical trials, enhancing the attractiveness of China as a destination for outsourcing services.

Growth in Biopharmaceutical Infrastructure to Drive Germany

Germany held 4.4% share in the global market in 2023 and is expected to grow at a CAGR of 1.6% during the forecasted period. Germany has established itself as a leading hub for biopharmaceutical innovation, focusing on advanced therapeutics. The country has a thriving biotechnology sector, research institutions, and a collaborative ecosystem that attracts domestic and international companies seeking outsourcing partners with expertise in cutting-edge therapies.

Germany is investing significantly in biopharmaceutical infrastructure, including state-of-the-art manufacturing facilities and research centers. This infrastructure supports outsourcing partners by providing access to cutting-edge technologies and specialized capabilities required for developing and manufacturing advanced therapeutics.

Rising Demand for Cutting-edge Treatments Driving Demand in Japan

Contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) are frequently used by pharmaceutical corporations to outsource different phases of the development process in Japan. Clinical trials, preclinical development, early-stage research, and commercial production are a few examples of these services.

Demand for cutting-edge treatments, such as gene and cell therapies, has increased in Japan. Pharmaceutical companies have been compelled by this demand to look outside for resources and experience to expedite development timeframes and manage the challenges of bringing new medicines to market.

Growing Technological Development Activities in Spain to Gain Traction

In sophisticated therapies, pharmaceutical companies frequently collaborate strategically with outsourcing partners in Spain. These partnerships seek to maximize resources, take advantage of each other's expertise, and hasten the creation and introduction of novel treatments. Technological developments like automation, analytics, and process optimization help manufacturers of advanced treatments operate more profitably and efficiently in Spain.

Category-wise Insights

The below section shows the commercial manufacturing and packaging segment dominated by phases category. It is forecast to thrive at an 4.0% CAGR between 2024 and 2034. Based on therapy, the gene therapy segment is anticipated to hold a dominant share through 2034. It is set to exhibit a CAGR of 3.8% during the forecast period.

Segment Value CAGR
Commercial Manufacturing and Packaging (Phases) 4.0%
Gene Therapy (Therapy) 3.8%
Oncology (Indication) 4.0%
Contract Development and Manufacturing Organizations (CDMOs) (Service Type) 3.7%

Demand to Remain High for Contract Development and Manufacturing Organizations

The contract development and manufacturing organizations (CDMOs) held 56.8% market share in 2023. CDMOs offer scalability and flexibility in manufacturing, allowing pharmaceutical companies to adapt production volumes based on the specific requirements of their therapies.

This flexibility is particularly crucial in the dynamic landscape of advanced therapeutics, where production needs may vary widely. CDMOs lead in the advanced therapeutics pharmaceutical outsourcing market due to their specialized expertise, developed infrastructure, flexibility, risk mitigation capabilities, regulatory compliance, cost efficiency, global reach, and collaborative approach to innovation.

Diversity and Scalability of Oncology to Make them Popular

The oncology market share in advanced therapeutics pharmaceutical outsourcing was 46.1% in 2023. The oncology pipeline is rich with innovative therapies, including gene therapies, CAR-T cell therapies, and mRNA-based treatments.

The diverse nature of these therapies necessitates specialized expertise and infrastructure, making outsourcing a strategic choice for pharmaceutical companies looking to bring novel oncology treatments to market. This trend will continue as the oncology landscape evolves with ongoing scientific and technological advancements.

Commercial Manufacturing and Packaging to Gain Momentum through 2034

Commercial manufacturing and packaging have a considerable presence in the advanced therapeutics pharmaceutical outsourcing market, accounting for 54.9% share in 2023. The commercial manufacturing and packaging services lead the market due to their pivotal role in scaling up production, managing supply chains, and contributing to the overall success of bringing advanced therapeutic products from development to commercialization.

Commercial manufacturing and packaging services are essential for scaling up production from clinical to commercial levels. As advanced therapeutic products progress through clinical trials and receive regulatory approval, the demand for large-scale manufacturing increases, making outsourcing partners with scale-up capabilities indispensable.

Competitive Landscape

Collaborations and acquisitions are the growth strategies that leading companies employ to enhance their capabilities, service offerings, and stay competitive in the dynamic landscape of advanced therapeutics.

  • In August 2022, Catalent Inc. acquired Metrics Contract Services and Contract Development and Manufacturing Organization (CDMO) in North Carolina.
  • In July 2022, Samsung Biologics Co. planned to double its manufacturing capacity by building four additional plants worth US$ 5.3 billion to solidify its leadership in the CDMO market.
  • In June 2022, Avid Bioservices launched analytical and process development labs within its viral vector development and CGMP manufacturing facility.

Scope of the Report

Attribute Details
Estimated Market Size (2024) US$ 7,592.8 million
Projected Market Size (2034) US$ 11,698.1 million
Anticipated Growth Rate (2024 to 2034) 4.4%
Forecast Period 2024 to 2034
Historical Data Available for 2019 to 2023
Market Analysis US$ million for Value
Key Regions Covered North America, Latin America, East Asia, South Asia and Pacific, Western Europe, Eastern Europe, Central Asia, Russia and Belarus, Balkan and Baltic Countries, Middle East and Africa
Key Countries Covered United States, Canada, Mexico, Brazil, Chile, China, Japan, South Korea, Germany, France, Spain, Italy, BENELUX, Nordic Countries, United Kingdom, BENELUX, Poland, Hungary, Romania, India, Association of Southeast Asian Nations Countries, Australia and New Zealand, GCC Countries, South Africa, Türkiye
Key Market Segments Covered Service Type, Indication, Therapy, Phases, and Region
Key Companies Profiled
  • Croda International Plc
  • Charles River Laboratories International, Inc.
  • Catalent, Inc.
  • QuintilesIMS (IQVIA)
  • Parexel International Corporation
  • ICON plc
  • PPD, Inc. (Thermo Fisher Scientific)
  • LabCorp (Laboratory Corporation of America Holdings)
  • Syneos Health
  • WuXi AppTec
  • Lonza Group
  • Piramal Pharma Solutions
  • SGS SA
  • Evotec SE
  • CMC Biologics (Now AGC Biologics)
  • Marken (A UPS Company)
  • Cytovance Biologics
  • Samsung Biologics
  • CordenPharma
  • Recipharm AB
  • Vetter Pharma International GmbH
  • Cryoport Systems, Inc.
  • ProPharma Group
  • Fujifilm Diosynth Biotechnologies
  • Medpace
  • Novotech Pty Ltd.
  • Axcella Health Inc.
  • CelerionAshland
Report Coverage Market Forecast, Competition Intelligence, Market Dynamics and Challenges, Strategic Growth Initiatives

Advanced Therapeutics Pharmaceutical Outsourcing Industry Segmentation

By Service Type:

  • Contract Research Organizations (CROs)
  • Contract Development and Manufacturing Organizations (CDMOs)

By Indication:

  • Oncology
  • Neurology
  • Cardiology
  • Infectious Diseases
  • Others

By Therapy:

  • Cell Therapy
  • Gene Therapy
  • RNA-based Therapies
  • Others

By Phases:

  • Preclinical Services
  • Clinical Services
  • Commercial Manufacturing and Packaging

By Region:

  • North America
  • Latin America
  • East Asia
  • South Asia and Pacific
  • Western Europe
  • Eastern Europe
  • Middle East and Africa

Frequently Asked Questions

How big was the global market in 2023?

The global market was valued at US$ 7,197.8 million in 2023.

What is the global market’s projected value for 2034?

The global market is set to reach a valuation of around US$ 11,698.1 million in 2034.

What was the historical CAGR for the global market?

Demand in the global market increased at a 3.3% CAGR from 2019 to 2023.

What value is the global market estimated to reach by 2024?

The global market is estimated to reach US$ 7,592.8 million by 2024.

What is the United States market outlook?

The United States accounted for around 32.6% share of the global market in 2023.

What is Germany’s market outlook?

Germany held around 4.4% share in the global market in 2023.

What is the outlook for China’s market?

China accounted for a market value share of around 7.9% in 2023 in the global market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply-Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

4. Value Added Insights

    4.1. Service Type Adoption, By Region

    4.2. Overview of CRO and CDMO Services

    4.3. Role of Contract Service Providers

    4.4. Regulatory Scenario, By Country

    4.5. Industry Deals

    4.6. PESTEL Analysis by Region

    4.7. PORTER Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global Healthcare Expenditure Outlook

        5.1.2. Global Research and Development Funding Outlook

        5.1.3. Global Life Expectancy Outlook

        5.1.4. Global Oncology Spending Outlook

        5.1.5. Growing Geriatric Population

    5.2. Forecast Factors - Relevance and Impact

        5.2.1. Increase in Research and Development Funding and Grants

        5.2.2. Increasing Incidence of Genetic Disorders

        5.2.3. Service Type Pipeline

        5.2.4. Service Type Innovation Trends

        5.2.5. Market Consolidation Activities

        5.2.6. Prevalence of Chronic Diseases

        5.2.7. Shift Towards Technologically Advanced Service Types

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. Global Market Demand (in Value or Size in US$ million) Analysis 2019 to 2023 and Forecast, 2024 to 2034

    6.1. Historical Market Value (US$ million) Analysis, 2019 to 2023

    6.2. Current and Future Market Value (US$ million) Projections, 2024 to 2034

        6.2.1. Y-o-Y Growth Trend Analysis

        6.2.2. Absolute $ Opportunity Analysis

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

    7.1. Introduction / Key Findings

    7.2. Historical Market Size (US$ million) By Service Type, 2019 to 2023

    7.3. Current and Future Market Size (US$ million) Analysis and Forecast By Service Type, 2024 to 2034

        7.3.1. Contract Research Organizations (CROs)

        7.3.2. Contract Development and Manufacturing Organizations (CDMOs)

    7.4. Market Attractiveness Analysis By Service Type

8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ million) Analysis By Indication, 2019 to 2023

    8.3. Current and Future Market Size (US$ million) Analysis and Forecast By Indication, 2024 to 2034

        8.3.1. Oncology

        8.3.2. Neurology

        8.3.3. Cardiology

        8.3.4. Infectious Diseases

        8.3.5. Others

    8.4. Market Attractiveness Analysis By Indication

9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ million) By Therapy, 2019 to 2023

    9.3. Current and Future Market Size (US$ million) Analysis and Forecast By Therapy, 2024 to 2034

        9.3.1. Cell Therapy

        9.3.2. Gene Therapy

        9.3.3. RNA-based Therapies

        9.3.4. Others

    9.4. Market Attractiveness Analysis By Therapy

10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ million) By Phases, 2019 to 2023

    10.3. Current and Future Market Size (US$ million) Analysis and Forecast By Phases, 2024 to 2034

        10.3.1. Preclinical Services

        10.3.2. Clinical Services

        10.3.3. Commercial Manufacturing and Packaging

    10.4. Market Attractiveness Analysis By Phases

11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ million) Analysis By Region, 2019 to 2023

    11.3. Current and Future Market Size (US$ million) Analysis and Forecast By Region, 2024 to 2034

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. East Asia

        11.3.4. South Asia and Pacific

        11.3.5. Western Europe

        11.3.6. Eastern Europe

        11.3.7. Middle East and Africa

    11.4. Market Attractiveness Analysis By Region

12. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    12.1. Introduction

    12.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023

    12.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034

        12.3.1. By Country

            12.3.1.1. United States

            12.3.1.2. Canada

            12.3.1.3. Mexico

        12.3.2. By Service Type

        12.3.3. By Indication

        12.3.4. By Therapy

        12.3.5. By Phases

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Service Type

        12.4.3. By Indication

        12.4.4. By Therapy

        12.4.5. By Phases

    12.5. Country Level Analysis and Forecast

        12.5.1. United States Market Analysis

            12.5.1.1. Introduction

            12.5.1.2. Market Analysis and Forecast by Market Taxonomy

                12.5.1.2.1. By Service Type

                12.5.1.2.2. By Indication

                12.5.1.2.3. By Therapy

                12.5.1.2.4. By Phases

        12.5.2. Canada Market Analysis

            12.5.2.1. Introduction

            12.5.2.2. Market Analysis and Forecast by Market Taxonomy

                12.5.2.2.1. By Service Type

                12.5.2.2.2. By Indication

                12.5.2.2.3. By Therapy

                12.5.2.2.4. By Phases

        12.5.3. Mexico Market Analysis

            12.5.3.1. Introduction

            12.5.3.2. Market Analysis and Forecast by Market Taxonomy

                12.5.3.2.1. By Service Type

                12.5.3.2.2. By Indication

                12.5.3.2.3. By Therapy

                12.5.3.2.4. By Phases

13. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    13.1. Introduction

    13.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023

    13.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034

        13.3.1. By Country

            13.3.1.1. Brazil

            13.3.1.2. Chile

            13.3.1.3. Rest of Latin America

        13.3.2. By Service Type

        13.3.3. By Indication

        13.3.4. By Therapy

        13.3.5. By Phases

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Service Type

        13.4.3. By Indication

        13.4.4. By Therapy

        13.4.5. By Phases

    13.5. Market Trends

    13.6. PESTEL Analysis

    13.7. Key Market Participants - Intensity Mapping

    13.8. Drivers and Restraints - Impact Analysis

    13.9. Country Level Analysis and Forecast

        13.9.1. Brazil Market Analysis

            13.9.1.1. Introduction

            13.9.1.2. Market Analysis and Forecast by Market Taxonomy

                13.9.1.2.1. By Service Type

                13.9.1.2.2. By Indication

                13.9.1.2.3. By Indication

                13.9.1.2.4. By Phases

        13.9.2. Chile Market Analysis

            13.9.2.1. Introduction

            13.9.2.2. Market Analysis and Forecast by Market Taxonomy

                13.9.2.2.1. By Service Type

                13.9.2.2.2. By Indication

                13.9.2.2.3. By Indication

                13.9.2.2.4. By Phases

14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    14.1. Introduction

    14.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023

    14.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034

        14.3.1. By Country

            14.3.1.1. China

            14.3.1.2. Japan

            14.3.1.3. South Korea

        14.3.2. By Service Type

        14.3.3. By Indication

        14.3.4. By Indication

        14.3.5. By Phases

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Service Type

        14.4.3. By Indication

        14.4.4. By Therapy

        14.4.5. By Phases

    14.5. Country Level Analysis and Forecast

        14.5.1. China Market Analysis

            14.5.1.1. Introduction

            14.5.1.2. Market Analysis and Forecast by Market Taxonomy

                14.5.1.2.1. By Service Type

                14.5.1.2.2. By Indication

                14.5.1.2.3. By Therapy

                14.5.1.2.4. By Phases

        14.5.2. Japan Market Analysis

            14.5.2.1. Introduction

            14.5.2.2. Market Analysis and Forecast by Market Taxonomy

                14.5.2.2.1. By Service Type

                14.5.2.2.2. By Indication

                14.5.2.2.3. By Therapy

                14.5.2.2.4. By Phases

        14.5.3. South Korea Market Analysis

            14.5.3.1. Introduction

            14.5.3.2. Market Analysis and Forecast by Market Taxonomy

                14.5.3.2.1. By Service Type

                14.5.3.2.2. By Indication

                14.5.3.2.3. By Therapy

                14.5.3.2.4. By Phases

15. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    15.1. Introduction

    15.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023

    15.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034

        15.3.1. By Country

            15.3.1.1. India

            15.3.1.2. Association of Southeast Asian Nations Countries

            15.3.1.3. Australia and New Zealand

            15.3.1.4. Rest of South Asia and Pacific

        15.3.2. By Service Type

        15.3.3. By Indication

        15.3.4. By Therapy

        15.3.5. By Phases

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Service Type

        15.4.3. By Indication

        15.4.4. By Therapy

        15.4.5. By Phases

    15.5. Country Level Analysis and Forecast

        15.5.1. India Market Analysis

            15.5.1.1. Introduction

            15.5.1.2. Market Analysis and Forecast by Market Taxonomy

                15.5.1.2.1. By Service Type

                15.5.1.2.2. By Indication

                15.5.1.2.3. By Therapy

                15.5.1.2.4. By Phases

        15.5.2. Association of Southeast Asian Nations Countries Market Analysis

            15.5.2.1. Introduction

            15.5.2.2. Market Analysis and Forecast by Market Taxonomy

                15.5.2.2.1. By Service Type

                15.5.2.2.2. By Indication

                15.5.2.2.3. By Therapy

                15.5.2.2.4. By Phases

        15.5.3. Australia and New Zealand Market Analysis

            15.5.3.1. Introduction

            15.5.3.2. Market Analysis and Forecast by Market Taxonomy

                15.5.3.2.1. By Service Type

                15.5.3.2.2. By Indication

                15.5.3.2.3. By Therapy

                15.5.3.2.4. By Phases

16. Western Europe Market 2019 to 2023 and Forecast 2024 to 2034

    16.1. Introduction

    16.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023

    16.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034

        16.3.1. By Country

            16.3.1.1. Germany

            16.3.1.2. Italy

            16.3.1.3. France

            16.3.1.4. United States

            16.3.1.5. Spain

            16.3.1.6. BENELUX

            16.3.1.7. Rest of Western Europe

        16.3.2. By Service Type

        16.3.3. By Indication

        16.3.4. By Therapy

        16.3.5. By Phases

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Service Type

        16.4.3. By Indication

        16.4.4. By Therapy

        16.4.5. By Phases

    16.5. Country Level Analysis and Forecast

        16.5.1. Germany Market Analysis

            16.5.1.1. Introduction

            16.5.1.2. Market Analysis and Forecast by Market Taxonomy

                16.5.1.2.1. By Service Type

                16.5.1.2.2. By Indication

                16.5.1.2.3. By Therapy

                16.5.1.2.4. By Phases

        16.5.2. France Market Analysis

            16.5.2.1. Introduction

            16.5.2.2. Market Analysis and Forecast by Market Taxonomy

                16.5.2.2.1. By Service Type

                16.5.2.2.2. By Indication

                16.5.2.2.3. By Therapy

                16.5.2.2.4. By Phases

        16.5.3. Spain Market Analysis

            16.5.3.1. Introduction

            16.5.3.2. Market Analysis and Forecast by Market Taxonomy

                16.5.3.2.1. By Service Type

                16.5.3.2.2. By Indication

                16.5.3.2.3. By Therapy

                16.5.3.2.4. By Phases

        16.5.4. Italy Market Analysis

            16.5.4.1. Introduction

            16.5.4.2. Market Analysis and Forecast by Market Taxonomy

                16.5.4.2.1. By Service Type

                16.5.4.2.2. By Indication

                16.5.4.2.3. By Therapy

                16.5.4.2.4. By Phases

        16.5.5. BENELUX Market Analysis

            16.5.5.1. Introduction

            16.5.5.2. Market Analysis and Forecast by Market Taxonomy

                16.5.5.2.1. By Service Type

                16.5.5.2.2. By Indication

                16.5.5.2.3. By Therapy

                16.5.5.2.4. By Phases

        16.5.6. United Kingdom Market Analysis

            16.5.6.1. Introduction

            16.5.6.2. Market Analysis and Forecast by Market Taxonomy

                16.5.6.2.1. By Service Type

                16.5.6.2.2. By Indication

                16.5.6.2.3. By Therapy

                16.5.6.2.4. By Phases

17. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    17.1. Introduction

    17.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023

    17.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034

        17.3.1. By Country

            17.3.1.1. Russia

            17.3.1.2. Hungary

            17.3.1.3. Poland

            17.3.1.4. Rest of Eastern Europe

        17.3.2. By Service Type

        17.3.3. By Indication

        17.3.4. By Therapy

        17.3.5. By Phases

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Service Type

        17.4.3. By Indication

        17.4.4. By Therapy

        17.4.5. By Indication

        17.4.6. By Phases

    17.5. Country Level Analysis and Forecast

        17.5.1. Russia Market Analysis

            17.5.1.1. Introduction

            17.5.1.2. Market Analysis and Forecast by Market Taxonomy

                17.5.1.2.1. By Service Type

                17.5.1.2.2. By Indication

                17.5.1.2.3. By Therapy

                17.5.1.2.4. By Phases

        17.5.2. Hungary Market Analysis

            17.5.2.1. Introduction

            17.5.2.2. Market Analysis and Forecast by Market Taxonomy

                17.5.2.2.1. By Service Type

                17.5.2.2.2. By Indication

                17.5.2.2.3. By Therapy

                17.5.2.2.4. By Phases

        17.5.3. Poland Market Analysis

            17.5.3.1. Introduction

            17.5.3.2. Market Analysis and Forecast by Market Taxonomy

                17.5.3.2.1. By Service Type

                17.5.3.2.2. By Indication

                17.5.3.2.3. By Therapy

                17.5.3.2.4. By Phases

18. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    18.1. Introduction

    18.2. Key Players Analyzed

    18.3. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023

    18.4. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034

        18.4.1. By Country

            18.4.1.1. Saudi Arabia

            18.4.1.2. Türkiye

            18.4.1.3. South Africa

            18.4.1.4. North Africa

            18.4.1.5. Rest of Middle East and Africa

        18.4.2. By Service Type

        18.4.3. By Indication

        18.4.4. By Therapy

        18.4.5. By Phases

    18.5. Market Attractiveness Analysis

        18.5.1. By Country

        18.5.2. By Service Type

        18.5.3. By Indication

        18.5.4. By Therapy

        18.5.5. By Indication

        18.5.6. By Phases

    18.6. Country Level Analysis and Forecast

        18.6.1. Saudi Arabia Market Analysis

            18.6.1.1. Introduction

            18.6.1.2. Market Analysis and Forecast by Market Taxonomy

                18.6.1.2.1. By Service Type

                18.6.1.2.2. By Indication

                18.6.1.2.3. By Therapy

                18.6.1.2.4. By Phases

        18.6.2. Türkiye Market Analysis

            18.6.2.1. Introduction

            18.6.2.2. Market Analysis and Forecast by Market Taxonomy

                18.6.2.2.1. By Service Type

                18.6.2.2.2. By Indication

                18.6.2.2.3. By Therapy

                18.6.2.2.4. By Phases

        18.6.3. South Africa Market Analysis

            18.6.3.1. Introduction

            18.6.3.2. Market Analysis and Forecast by Market Taxonomy

                18.6.3.2.1. By Service Type

                18.6.3.2.2. By Indication

                18.6.3.2.3. By Therapy

                18.6.3.2.4. By Phases

        18.6.4. North Africa Market Analysis

            18.6.4.1. Introduction

            18.6.4.2. Market Analysis and Forecast by Market Taxonomy

                18.6.4.2.1. By Service Type

                18.6.4.2.2. By Indication

                18.6.4.2.3. By Therapy

                18.6.4.2.4. By Phases

19. Market Structure Analysis

    19.1. Market Analysis by Tier of Companies

    19.2. Market Share Analysis of Top Companies

    19.3. Market Presence Analysis

20. Competition Analysis

    20.1. Competition Benchmarking

    20.2. Competition Dashboard

    20.3. Key Development Analysis

    20.4. Key Promotional Strategies, By Manufacturers

    20.5. Competition Deep Dive

        20.5.1. Charles River Laboratories International, Inc.

            20.5.1.1. Overview

            20.5.1.2. Service Portfolio

            20.5.1.3. Sales Footprint

            20.5.1.4. Key Financials

            20.5.1.5. Key Developments

            20.5.1.6. Strategy Overview

            20.5.1.7. SWOT Analysis

        20.5.2. Catalent, Inc.

        20.5.3. QuintilesIMS (IQVIA)

        20.5.4. Parexel International Corporation

        20.5.5. ICON plc

        20.5.6. PPD, Inc. (Thermo Fisher Scientific)

        20.5.7. LabCorp (Laboratory Corporation of America Holdings)

        20.5.8. Syneos Health

        20.5.9. WuXi AppTec

        20.5.10. Lonza Group

        20.5.11. Piramal Pharma Solutions

        20.5.12. SGS SA

        20.5.13. Evotec SE

        20.5.14. CMC Biologics (Now AGC Biologics)

        20.5.15. Marken (A UPS Company)

        20.5.16. Cytovance Biologics

        20.5.17. Samsung Biologics

        20.5.18. CordenPharma

        20.5.19. Recipharm AB

        20.5.20. Vetter Pharma International GmbH

        20.5.21. Cryoport Systems, Inc.

        20.5.22. ProPharma Group

        20.5.23. Fujifilm Diosynth Biotechnologies

        20.5.24. Medpace

        20.5.25. Novotech Pty Ltd.

        20.5.26. Axcella Health Inc.

        20.5.27. Celerion

21. Assumptions and Acronyms Used

22. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 1: Global Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 2: Global Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 3: Global Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 4: Global Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 5: Global Market Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

Table 6: North America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

Table 7: North America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 8: North America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 9: North America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 10: North America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 11: United States Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 12: United States Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 13: United States Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 14: United States Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 15: Canada Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 16: Canada Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 17: Canada Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 18: Canada Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 19: Mexico Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 20: Mexico Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 21: Mexico Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 22: Mexico Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 23: Latin America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

Table 24: Latin America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 25: Latin America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 26: Latin America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 27: Latin America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 28: Brazil Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 29: Brazil Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 30: Brazil Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 31: Brazil Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 32: Chile Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 33: Chile Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 34: Chile Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 35: Chile Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 36: East Asia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

Table 37: East Asia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 38: East Asia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 39: East Asia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 40: East Asia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 41: China Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 42: China Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 43: China Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 44: China Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 45: Japan Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 46: Japan Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 47: Japan Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 48: Japan Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 49: South Korea Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 50: South Korea Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 51: South Korea Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 52: South Korea Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 53: South Asia and Pacific Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

Table 54: South Asia and Pacific Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 55: South Asia and Pacific Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 56: South Asia and Pacific Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 57: South Asia and Pacific Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 58: India Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 59: India Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 60: India Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 61: India Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 62: Association of Southeast Asian Nations Countries Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 63: Association of Southeast Asian Nations Countries Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 64: Association of Southeast Asian Nations Countries Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 65: Association of Southeast Asian Nations Countries Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 66: Australia and New Zealand Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 67: Australia and New Zealand Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 68: Australia and New Zealand Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 69: Australia and New Zealand Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 70: Western Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

Table 71: Western Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 72: Western Europe Market (Units) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 73: Western Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 74: Western Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 75: Western Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 76: Germany Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 77: Germany Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 78: Germany Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 79: Germany Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 80: Italy Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 81: Italy Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 82: Italy Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 83: Italy Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 84: France Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 85: France Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 86: France Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 87: France Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 88: United Kingdom Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 89: United Kingdom Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 90: United Kingdom Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 91: United Kingdom Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 92: Spain Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 93: Spain Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 94: Spain Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 95: Spain Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 96: BENELUX Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 97: BENELUX Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 98: BENELUX Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 99: BENELUX Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 100: Nordic Countries Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 101: Nordic Countries Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 102: Nordic Countries Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 103: Nordic Countries Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 104: Eastern Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

Table 105: Eastern Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 106: Eastern Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 107: Eastern Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 108: Eastern Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 109: Russia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 110: Russia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 111: Russia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 112: Russia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 113: Hungary Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 114: Hungary Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 115: Hungary Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 116: Hungary Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 117: Poland Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 118: Poland Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 119: Poland Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 120: Poland Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 121: Middle East and Africa Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

Table 122: Middle East and Africa Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 123: Middle East and Africa Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 124: Middle East and Africa Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 125: Middle East and Africa Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 126: Saudi Arabia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 127: Saudi Arabia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 128: Saudi Arabia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 129: Saudi Arabia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 130: Türkiye Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 131: Türkiye Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 132: Türkiye Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 133: Türkiye Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 134: South Africa Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 135: South Africa Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 136: South Africa Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 137: South Africa Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases

Table 138: Other Africa Union Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type

Table 139: Other Africa Union Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

Table 140: Other Africa Union Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy

Table 141: Other Africa Union Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Global Market Value Share By Service Type 2023 (A)

Figure 2: Global Market Value Share By Indication 2023 (A)

Figure 3: Global Market Value Share By Therapy 2023 (A)

Figure 4: Global Market Value Share By Phases 2023 (A)

Figure 5: Global Market Value Share By Country 2023 (A)

Figure 6: Global Market Value Analysis (US$ million), 2019 to 2023

Figure 7: Global Market Value Forecast (US$ million), 2024 to 2034

Figure 8: Global Market Absolute $ Opportunity, 2024 to 2034

Figure 9: Global Market Share Analysis (%), By Service Type, 2024 (E) to 2034 (F)

Figure 10: Global Market Y-o-Y Analysis (%), By Service Type, 2024 to 2034

Figure 11: Global Market Attractiveness Analysis, By Service Type

Figure 12: Global Market Share Analysis (%), By Indication , 2024 (E) to 2034 (F)

Figure 13: Global Market Y-o-Y Analysis (%), By Indication, 2024 to 2034

Figure 14: Global Market Attractiveness Analysis, By Indication

Figure 15: Global Market Share Analysis (%), By Therapy, 2024 (E) to 2034 (F)

Figure 16: Global Market Y-o-Y Analysis (%), By Therapy, 2024 to 2034

Figure 17: Global Market Attractiveness Analysis, By Therapy

Figure 18: Global Market Share Analysis (%), By Phases, 2024 (E) to 2034 (F)

Figure 19: Global Market Y-o-Y Analysis (%), By Phases, 2024 to 2034

Figure 20: Global Market Attractiveness Analysis, By Phases

Figure 21: Global Market Share Analysis (%), By Region, 2024 (E) to 2034 (F)

Figure 22: Global Market Y-o-Y Analysis (%), By Region, 2024 to 2034

Figure 23: Global Market Attractiveness Analysis By Region, 2024 to 2034

Figure 24: North America Market Value Share By Service Type 2023 (A)

Figure 25: North America Market Value Share By Indication 2023 (A)

Figure 26: North America Market Value Share By Therapy 2023 (A)

Figure 27: North America Market Value Share By Phases 2023 (A)

Figure 28: North America Market Value Share By Country 2023 (A)

Figure 29: North America Market Value (US$ million) Analysis, 2019 to 2023

Figure 30: North America Market Forecast and Y-o-Y growth, 2024 to 2034

Figure 31: North America Market Attractiveness Analysis By Service Type, 2024 to 2034

Figure 32: North America Market Attractiveness Analysis By Indication, 2024 to 2034

Figure 33: North America Market Attractiveness Analysis By Therapy, 2024 to 2034

Figure 34: North America Market Attractiveness Analysis By Phases, 2024 to 2034

Figure 35: North America Market Attractiveness Analysis By Country, 2024 to 2034

Figure 36: Latin America Market Value Share By Service Type 2023 (A)

Figure 37: Latin America Market Value Share By Indication 2023 (A)

Figure 38: Latin America Market Value Share By Therapy 2023 (A)

Figure 39: Latin America Market Value Share By Phases 2023 (A)

Figure 40: Latin America Market Value Share By Country 2023 (A)

Figure 41: Latin America Market Value (US$ million) Analysis, 2019 to 2023

Figure 42: Latin America Market Forecast and Y-o-Y growth, 2024 to 2034

Figure 43: Latin America Market Attractiveness Analysis By Service Type, 2024 to 2034

Figure 44: Latin America Market Attractiveness Analysis By Indication, 2024 to 2034

Figure 45: Latin America Market Attractiveness Analysis By Therapy, 2024 to 2034

Figure 46: Latin America Market Attractiveness Analysis By Phases, 2024 to 2034

Figure 47: Latin America Market Attractiveness Analysis By Country, 2024 to 2034

Figure 48: East Asia Market Value Share By Service Type 2023 (A)

Figure 49: East Asia Market Value Share By Indication 2023 (A)

Figure 50: East Asia Market Value Share By Therapy 2023 (A)

Figure 51: East Asia Market Value Share By Phases 2023 (A)

Figure 52: East Asia Market Value Share By Country 2023 (A)

Figure 53: East Asia Market Value (US$ million) Analysis, 2019 to 2023

Figure 54: East Asia Market Forecast and Y-o-Y growth, 2024 to 2034

Figure 55: East Asia Market Attractiveness Analysis By Service Type, 2024 to 2034

Figure 56: East Asia Market Attractiveness Analysis By Indication, 2024 to 2034

Figure 57: East Asia Market Attractiveness Analysis By Therapy, 2024 to 2034

Figure 58: East Asia Market Attractiveness Analysis By Phases, 2024 to 2034

Figure 59: East Asia Market Attractiveness Analysis By Country, 2024 to 2034

Figure 60: South Asia and Pacific Market Value Share By Service Type 2023 (A)

Figure 61: South Asia and Pacific Market Value Share By Indication 2023 (A)

Figure 62: South Asia and Pacific Market Value Share By Therapy 2023 (A)

Figure 63: South Asia and Pacific Market Value Share By Phases 2023 (A)

Figure 64: South Asia and Pacific Market Value Share By Country 2023 (A)

Figure 65: South Asia and Pacific Market Value (US$ million) Analysis, 2019 to 2023

Figure 66: South Asia and Pacific Market Forecast and Y-o-Y growth, 2024 to 2034

Figure 67: South Asia and Pacific Market Attractiveness Analysis By Service Type, 2024 to 2034

Figure 68: South Asia and Pacific Market Attractiveness Analysis By Indication, 2024 to 2034

Figure 69: South Asia and Pacific Market Attractiveness Analysis By Therapy, 2024 to 2034

Figure 70: South Asia and Pacific Market Attractiveness Analysis By Phases, 2024 to 2034

Figure 71: South Asia and Pacific Market Attractiveness Analysis By Country, 2024 to 2034

Figure 72: Western Europe Market Value Share By Service Type 2023 (A)

Figure 73: Western Europe Market Value Share By Indication 2023 (A)

Figure 74: Western Europe Market Value Share By Therapy 2023 (A)

Figure 75: Western Europe Market Value Share By Phases 2023 (A)

Figure 76: Western Europe Market Value Share By Country 2023 (A)

Figure 77: Western Europe Market Value (US$ million) Analysis, 2019 to 2023

Figure 78: Western Europe Market Forecast and Y-o-Y growth, 2024 to 2034

Figure 79: Western Europe Market Attractiveness Analysis By Service Type, 2024 to 2034

Figure 80: Western Europe Market Attractiveness Analysis By Indication, 2024 to 2034

Figure 81: Western Europe Market Attractiveness Analysis By Therapy, 2024 to 2034

Figure 82: Western Europe Market Attractiveness Analysis By Phases, 2024 to 2034

Figure 83: Western Europe Market Attractiveness Analysis By Country, 2024 to 2034

Figure 84: Eastern Europe Market Value Share By Service Type 2023 (A)

Figure 85: Eastern Europe Market Value Share By Indication 2023 (A)

Figure 86: Eastern Europe Market Value Share By Therapy 2023 (A)

Figure 87: Eastern Europe Market Value Share By Phases 2023 (A)

Figure 88: Eastern Europe Market Value Share By Country 2023 (A)

Figure 89: Eastern Europe Market Value (US$ million) Analysis, 2019 to 2023

Figure 90: Eastern Europe Market Forecast and Y-o-Y growth, 2024 to 2034

Figure 91: Eastern Europe Market Attractiveness Analysis By Service Type, 2024 to 2034

Figure 92: Eastern Europe Market Attractiveness Analysis By Indication, 2024 to 2034

Figure 93: Eastern Europe Market Attractiveness Analysis By Therapy, 2024 to 2034

Figure 94: : Eastern Europe Market Attractiveness Analysis By Phases, 2024 to 2034

Figure 95: : Eastern Europe Market Attractiveness Analysis By Country, 2024 to 2034

Figure 96: : Middle East and Africa Market Value Share By Service Type 2023 (A)

Figure 97: : Middle East and Africa Market Value Share By Indication 2023 (A)

Figure 98: : Middle East and Africa Market Value Share By Therapy 2023 (A)

Figure 99: : Middle East and Africa Market Value Share By Phases 2023 (A)

Figure 100: : Middle East and Africa Market Value Share By Country 2023 (A)

Figure 101: : Middle East and Africa Market Value (US$ million) Analysis, 2019 to 2023

Figure 102: : Middle East and Africa Market Forecast and Y-o-Y growth, 2024 to 2034

Figure 103: : Middle East and Africa Market Attractiveness Analysis By Service Type, 2024 to 2034

Figure 104: : Middle East and Africa Market Attractiveness Analysis By Indication, 2024 to 2034

Figure 105: : Middle East and Africa Market Attractiveness Analysis By Therapy, 2024 to 2034

Figure 106: : Middle East and Africa Market Attractiveness Analysis By Phases, 2024 to 2034

Figure 107: : Middle East and Africa Market Attractiveness Analysis By Country, 2024 to 2034

Recommendations

Healthcare

Distance Health Technology Market

Published : December 2023

Healthcare

Topical Pain Relief Market

Published : December 2023

Healthcare

Vitamin and Mineral Supplement Market

Published : December 2023

Healthcare

Infection Prevention Market

Published : December 2023

Explore Healthcare Insights

View Reports

Advanced Therapeutics Pharmaceutical Outsourcing Market